This inventor holds 2 USPTO granted patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Yasumitsu Tamura. Active years: 1988-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1993
Title: Yasumitsu Tamura: Innovator in Pharmaceutical Chemistry
Introduction
Yasumitsu Tamura is a notable inventor based in Takarazuka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Tamura's work has had a considerable impact on medical science.
Latest Patents
One of Yasumitsu Tamura's latest patents involves novel indole derivatives. These compounds possess an inhibitory effect against superoxide (O.sub.2.sup.-) released from guinea pig macrophage cells upon stimulation. They also exhibit anti-albuminuria activity against Masugi nephritis. This makes them useful in various clinical fields for preventing and treating diseases associated with superoxide radicals, such as autoimmune diseases, arteriosclerosis, ischemic diseases, hepatic insufficiency, and renal insufficiency. Another patent focuses on the method of preparing alpha-arylalkanoic esters, which are synthesized by reacting a trivalent iodine compound.
Career Highlights
Throughout his career, Yasumitsu Tamura has worked with prominent organizations, including Otsuka Pharmaceutical Company, Limited. His expertise in pharmaceutical chemistry has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Tamura has collaborated with notable colleagues in his field, including Hitoshi Tone and Seiji Sato. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yasumitsu Tamura's contributions to pharmaceutical chemistry through his patents demonstrate his commitment to innovation and improving healthcare. His work continues to influence the medical field, showcasing the importance of research and development in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
